TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/7/23 18:35 | 2/2/23 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | Violin Jonathan | MA | DO | Chief E | S.ad | -1,840 | 36.80 | 0 | -50 | -9 | 481 | D | ||||||||||||||
2/3/23 18:12 | 2/2/23 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | Violin Jonathan | MA | DO | Chief E | S | -1,840 | 36.80 | 0 | -50 | -10 | 431 | D | ||||||||||||||
6/2/22 17:29 | 6/1/22 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | Violin Jonathan | MA | DO | Chief E | S | -366 | 12.20 | 0 | -30 | -6 | 481 | D | ||||||||||||||
5/4/22 17:23 | 5/2/22 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | Violin Jonathan | MA | DO | CEO | S | -391 | 13.04 | 0 | -30 | -6 | 511 | D | ||||||||||||||
4/5/22 18:09 | 4/1/22 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | Violin Jonathan | MA | DO | Chief E | S.m | -568 | 18.92 | 0 | -30 | -5 | 541 | D | ||||||||||||||
3/3/22 16:48 | 3/1/22 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | Violin Jonathan | MA | DO | Chief E | S.m | -529 | 17.65 | 0 | -30 | -5 | 571 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |